Frontiers in Oncology | Breast Cancer

Original Research

Published on 24 Jul 2024

Comparative cost-effectiveness analysis of CDK4/6 inhibitors in the first-line treatment of HR-positive and HER2-negative advanced breast cancer: a Markov's model-based evaluation

in Breast Cancer

Shereen Elazzazy
Nour Hisham Al-Ziftawi
Mohamed Izham Mohamed Ibrahim
Salha Bujassoum
Anas Hamad

Frontiers in Oncology

doi 10.3389/fonc.2024.1413676

6,076 views
5 citations

Original Research

Published on 23 Jul 2024

Management and outcomes of breast cancer patients with radiotherapy interruption

in Breast Cancer

Fangrui Zhao
Dashuai Yang
Yanfang Lan
Xiangpan Li

Frontiers in Oncology

doi 10.3389/fonc.2024.1337194

2,527 views

Original Research

Published on 17 Jul 2024

Thromboelastogram and coagulation function index: relevance for female breast cancer

in Breast Cancer

Qiongle Peng
Jinmei Zhu
Xiaoling Ren

Frontiers in Oncology

doi 10.3389/fonc.2024.1342439

4,085 views
6 citations

Perspective

Published on 16 Jul 2024

Comprehensive strategies in breast cancer-related lymphedema prevention: insights from a multifaceted program

in Breast Cancer

Fardeen Bhimani
Maureen McEvoy
Yu Chen
Anjuli Gupta
Jessica Pastoriza
Arianna Cavalli
Liane Obaid
Carolyn Rachofsky
Shani Fruchter
Sheldon Feldman

Frontiers in Oncology

doi 10.3389/fonc.2024.1418610

5,252 views
6 citations

Original Research

Published on 11 Jul 2024

Predicting Ki-67 expression levels in breast cancer using radiomics-based approaches on digital breast tomosynthesis and ultrasound

in Breast Cancer

Jie Liu
Caiying Yan
Chenlu Liu
Yanxiao Wang
Qian Chen
Ying Chen
Jianfeng Guo
Shuangqing Chen

Frontiers in Oncology

doi 10.3389/fonc.2024.1403522

2,986 views
4 citations

Original Research

Published on 08 Jul 2024

ECM1 and ANXA1 in urinary extracellular vesicles serve as biomarkers for breast cancer

in Breast Cancer

Hai Huang
Jingyu Wan
Xudong Ao
Shuang Qu
Meng Jia
Keyu Zhao
Junqing Liang
Ke Zen
Hongwei Liang

Frontiers in Oncology

doi 10.3389/fonc.2024.1408492

5,870 views
9 citations

Review

Published on 08 Jul 2024

Recent progress in Surface-Enhanced Raman Spectroscopy detection of biomarkers in liquid biopsy for breast cancer

in Breast Cancer

Xiaobei Liu
Yining Jia
Chao Zheng

Frontiers in Oncology

doi 10.3389/fonc.2024.1400498

6,300 views
11 citations

Original Research

Published on 01 Jul 2024

Correlation between fasting blood glucose level and risk of breast cancer in women: a single-center, prospective cohort study

in Breast Cancer

Gefei Li
Mingjie Yin
Zhimin Fan
Fengjiang Qu

Frontiers in Oncology

doi 10.3389/fonc.2024.1359839

3,343 views
4 citations

Original Research

Published on 27 Jun 2024

What are the needs in oral antitumor therapy? An analysis of patients’ and practitioners’ preferences

in Breast Cancer

Anna Hester
Franziska Henze
Anna Marie Debes
Charlotte Leonie Schubert
Alexander Koenig
Nadia Harbeck
Rachel Wuerstlein

Frontiers in Oncology

doi 10.3389/fonc.2024.1388087

3,448 views
2 citations

Systematic Review

Published on 27 Jun 2024

Mechanisms of traditional Chinese medicine overcoming of radiotherapy resistance in breast cancer

in Breast Cancer

Xiaohui Zhao
Ting Luo
Yuting Qiu
Zhiwei Yang
Danni Wang
Zairui Wang
Jiale Zeng
Zhuofei Bi

Frontiers in Oncology

doi 10.3389/fonc.2024.1388750

3,995 views
6 citations

Original Research

Published on 26 Jun 2024

Low progesterone receptor levels in high-grade DCIS correlate with HER2 upregulation and the presence of invasive components

in Breast Cancer

Hossein Schandiz
Lorant Farkas
Daehoon Park
Yan Liu
Solveig N. Andersen
Jürgen Geisler
Torill Sauer

Frontiers in Oncology

doi 10.3389/fonc.2024.1347166

3,244 views
1 citation

Original Research

Published on 24 Jun 2024

Long-term oncologic outcomes following breast cancer surgery in adolescents and young adults: a single-center retrospective analysis

in Breast Cancer

Xin Liu
Zengyan Ma
Hongwu Chu
Weihong Nie
Guoxin Sun
Kaihua Zhao
Xiao Zou

Frontiers in Oncology

doi 10.3389/fonc.2024.1364608

2,112 views
1 citation

Systematic Review

Published on 24 Jun 2024

Germline rare variants in HER2-positive breast cancer predisposition: a systematic review and meta-analysis

in Breast Cancer

Angelica Cerveira de Baumont
Nathan Araujo Cadore
Luana Giongo Pedrotti
Giovana Dallaio Curzel
Jaqueline Bohrer Schuch
Marina Bessel
Cláudia Bordignon
Mahira Lopes Rosa
Gabriel de Souza Macedo
Daniela Dornelles Rosa

Frontiers in Oncology

doi 10.3389/fonc.2024.1395970

4,526 views
3 citations

Case Report

Published on 20 Jun 2024

Recurrent and transformation of borderline to malignant phyllodes tumour with osteoid differentiation: a case report and literature review

in Breast Cancer

Navin Raj Balachandran
Norlia Abdullah
Muhammad Ishamuddin Ismail
Yin Ping Wong
Mohd Imree Azmi

Frontiers in Oncology

doi 10.3389/fonc.2024.1377074

2,772 views
3 citations

Original Research

Published on 20 Jun 2024

The global burden of breast cancer in women from 1990 to 2030: assessment and projection based on the global burden of disease study 2019

in Breast Cancer

Song Zhang
Zhihui Jin
Lingling Bao
Peng Shu

Frontiers in Oncology

doi 10.3389/fonc.2024.1364397

10,035 views
39 citations

Original Research

Published on 18 Jun 2024

Is the percentage of hormone receptor positivity in HR+ HER2-metastatic breast cancer patients receiving CDK 4/6 inhibitor with endocrine therapy predictive and prognostic?

in Breast Cancer

Merve Keskinkilic
Huseyin Salih Semiz
Tugba Yavuzsen
Ilhan Oztop

Frontiers in Oncology

doi 10.3389/fonc.2024.1378563

3,357 views
2 citations

Case Report

Published on 17 Jun 2024

Partial response to trastuzumab deruxtecan (DS8201) following progression in HER2-amplified breast cancer with pulmonary metastases managed with disitamab vedotin (RC48): a comprehensive case report and literature review

in Breast Cancer

Yanfang Lan
Jiahui Zhao
Fangrui Zhao
Juanjuan Li
Xiangpan Li

Frontiers in Oncology

doi 10.3389/fonc.2024.1338661

4,875 views
1 citation

Original Research

Published on 17 Jun 2024

The somatic mutation profile of estrogen receptor-positive HER2-negative metastatic breast cancer in Brazilian patients

in Breast Cancer

Tomás Reinert
Fernanda Orpinelli do Rego
Matheus Costa e Silva
Amanda Muniz Rodrigues
Fernanda Christtanini Koyama
Aline Coelho Gonçalves
Maiane Maria Pauletto
Leandro Jonata de Carvalho Oliveira
Cristiano Augusto Andrade de Resende
Luciana Castro Garcia Landeiro

Frontiers in Oncology

doi 10.3389/fonc.2024.1372947

4,234 views
3 citations

Original Research

Published on 14 Jun 2024

Relationship between age at menarche and breast cancer in individuals, as well as in first-degree kin and estrogen receptor status: a Mendelian randomization study

in Breast Cancer

Zhijun Zhao
Jinming Zhang
Xiaofeng Tian

Frontiers in Oncology

doi 10.3389/fonc.2024.1408132

2,760 views
1 citation

Original Research

Published on 14 Jun 2024

Development and validation of AI models using LR and LightGBM for predicting distant metastasis in breast cancer: a dual-center study

in Breast Cancer

Wen-hai Zhang
Yang Tan
Zhen Huang
Qi-xing Tan
Yue-mei Zhang
Bin-jie Chen
Chang-yuan Wei

Frontiers in Oncology

doi 10.3389/fonc.2024.1409273

2,859 views
4 citations

Case Report

Published on 11 Jun 2024

Hemophagocytic lymphohistiocytosis/cytokine release syndrome secondary to neoadjuvant pembrolizumab for triple-negative breast cancer: a case study

in Breast Cancer

Laura Patton
Bethany Monteith
Paul Heffernan
Thomas Herzinger
Brooke E. Wilson

Frontiers in Oncology

doi 10.3389/fonc.2024.1394543

3,791 views
7 citations

Original Research

Published on 10 Jun 2024

Triple-negative breast cancer survival prediction: population-based research using the SEER database and an external validation cohort

in Breast Cancer

Yu Qiu
Yan Chen
Haoyang Shen
Shuixin Yan
Jiadi Li
Weizhu Wu

Frontiers in Oncology

doi 10.3389/fonc.2024.1388869

4,827 views
6 citations

Original Research

Published on 07 Jun 2024

Tailoring advanced breast cancer treatment after cyclin-dependent kinase 4/6 inhibitors progression - real-world data analysis

in Breast Cancer

Marcin Kubeczko
Anna Polakiewicz-Gilowska
Katarzyna Świderska
Aleksandra Leśniak
Marta Mianowska-Malec
Barbarba Łanoszka
Konstanty Chomik
Barbara Grandys
Natalya Lisovska
Barbara Bobek-Billewicz

Frontiers in Oncology

doi 10.3389/fonc.2024.1408664

3,701 views
2 citations

Systematic Review

Published on 06 Jun 2024

Effect of frozen gloves on chemotherapy-induced neurotoxicity in breast cancer patients: a systematic review and meta-analysis

in Breast Cancer

Hongting Wu
Ying Jin
Jiaqing Song
Xiufei Gao

Frontiers in Oncology

doi 10.3389/fonc.2024.1366782

7,731 views
6 citations

1,708 articles

articles

Comparative cost-effectiveness analysis of CDK4/6 inhibitors in the first-line treatment of HR-positive and HER2-negative advanced breast cancer: a Markov's model-based evaluation

Management and outcomes of breast cancer patients with radiotherapy interruption

Thromboelastogram and coagulation function index: relevance for female breast cancer

Comprehensive strategies in breast cancer-related lymphedema prevention: insights from a multifaceted program

Predicting Ki-67 expression levels in breast cancer using radiomics-based approaches on digital breast tomosynthesis and ultrasound

ECM1 and ANXA1 in urinary extracellular vesicles serve as biomarkers for breast cancer

Recent progress in Surface-Enhanced Raman Spectroscopy detection of biomarkers in liquid biopsy for breast cancer

Correlation between fasting blood glucose level and risk of breast cancer in women: a single-center, prospective cohort study

What are the needs in oral antitumor therapy? An analysis of patients’ and practitioners’ preferences

Mechanisms of traditional Chinese medicine overcoming of radiotherapy resistance in breast cancer

Low progesterone receptor levels in high-grade DCIS correlate with HER2 upregulation and the presence of invasive components

Long-term oncologic outcomes following breast cancer surgery in adolescents and young adults: a single-center retrospective analysis

Germline rare variants in HER2-positive breast cancer predisposition: a systematic review and meta-analysis

Recurrent and transformation of borderline to malignant phyllodes tumour with osteoid differentiation: a case report and literature review

The global burden of breast cancer in women from 1990 to 2030: assessment and projection based on the global burden of disease study 2019

Is the percentage of hormone receptor positivity in HR+ HER2-metastatic breast cancer patients receiving CDK 4/6 inhibitor with endocrine therapy predictive and prognostic?

Partial response to trastuzumab deruxtecan (DS8201) following progression in HER2-amplified breast cancer with pulmonary metastases managed with disitamab vedotin (RC48): a comprehensive case report and literature review

The somatic mutation profile of estrogen receptor-positive HER2-negative metastatic breast cancer in Brazilian patients

Relationship between age at menarche and breast cancer in individuals, as well as in first-degree kin and estrogen receptor status: a Mendelian randomization study

Development and validation of AI models using LR and LightGBM for predicting distant metastasis in breast cancer: a dual-center study

Hemophagocytic lymphohistiocytosis/cytokine release syndrome secondary to neoadjuvant pembrolizumab for triple-negative breast cancer: a case study

Triple-negative breast cancer survival prediction: population-based research using the SEER database and an external validation cohort

Tailoring advanced breast cancer treatment after cyclin-dependent kinase 4/6 inhibitors progression - real-world data analysis

Effect of frozen gloves on chemotherapy-induced neurotoxicity in breast cancer patients: a systematic review and meta-analysis